ImpediMed enters med-tech partnership with Redox

Company News

by David Chau

Medical device company, ImpediMed Limited (ASX:IPD), has entered a strategic partnership with med-tech company, Redox.

ImpediMed says this partnership will expand the capabilities of its Electronic Health Record (EHR) integration in regards to its next generation medical devices.

The company says the new device will use ImpediMed’s BIS technology to measure, monitor and manage fluid status and body composition.

Combined with Redox’s programming interface for EHR integration, ImpediMed says it can streamline the inter-operability of its device with multiple EHR vendors to create a user-friendly and data rich tech solution.

ImpediMed reported a net loss of $11.2 million at 31 December 2015.

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.